All Stories

  1. Identification of Active Phytochemicals to Inhibit Signal Transducer and Activator of Transcription 5A (STAT5A) Dimerization for Prostate Cancer Therapy: An In Silico Approach

    Article • Anti-Cancer Agents in Medicinal Chemistry, November 2025, Bentham Science Publishers

    Dr Shyam Sundar Pottabathula

  2. Development and characterization of ethosomes of Acacia senegal for improved topical treatment of breast cancer

    Article • Next Materials, July 2025, Elsevier

    Dr Shyam Sundar Pottabathula

  3. Design and Characterization of Dapsone Nanoemulgel for Treatment of Acne Vulgaris

    Article • Indian Journal of Pharmaceutical Education and Research, May 2025, EManuscript Services

    Dr Shyam Sundar Pottabathula

  4. A New Class of BRCA1 Mimetics for ERα-Positive Breast Cancer Therapy: Design, Synthesis, In Silico Screening, In Vitro Assay, and Gene Expression Analysis

    Article • Life, April 2025, MDPI AG

    Dr Shyam Sundar Pottabathula

  5. Computational Screening of Some Phytochemicals to Identify Best Modulators for Ligand Binding Domain of Estrogen Receptor Alpha

    Article • Current Pharmaceutical Design, June 2024, Bentham Science Publishers

    veerasamy Alagarsamy, Mr Sabarees Govindaraj, Sulthana M T, Viswas Raja Solomon, Dr Shyam Sundar Pottabathula

  6. In Silico Screening of Some Active Phytochemicals to Identify Promising Inhibitors Against SARS-CoV-2 Targets

    Article • Current Drug Discovery Technologies, May 2024, Bentham Science Publishers

    Dr Shyam Sundar Pottabathula

  7. Exploring Anticancer Potential of Camptothecin Isolated from Nothapodytes Nimmonianain the Treatment of Prostate and Lung Carcinoma

    Article • International Journal of Pharmaceutical Sciences and Nanotechnology, February 2024, BSP Books Private Limited

    Dr Shyam Sundar Pottabathula

  8. Alpinia galanga bioactive constituents as multi-target inhibitors of SARS-CoV-2 proteins: A molecular docking, molecular simulation and ADMET analysis

    Article • Traditional Medicine Research, January 2024, TMR Publishing Group

    Dr Shyam Sundar Pottabathula

  9. An In silico Investigation to Identify Promising Inhibitors for SARS-CoV-2 Mpro Target

    Article • Medicinal Chemistry, November 2023, Bentham Science Publishers

    Dr Shyam Sundar Pottabathula, veerasamy Alagarsamy, Jubie Jawahar, Viswas Raja Solomon, Sulthana M T, Kotha Rohitha

  10. Screening Active Phytochemicals of Some Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 M pro by Computational Investigation

    Article • Letters in Drug Design & Discovery, September 2023, Bentham Science Publishers

    Dr Shyam Sundar Pottabathula, veerasamy Alagarsamy, Sulthana M T, Viswas Raja Solomon

  11. Pharmacophore modelling-based drug repurposing approaches for monkeypox therapeutics

    Article • Journal of Biomolecular Structure and Dynamics, March 2023, Taylor & Francis

    Dr Shyam Sundar Pottabathula, Viswas Raja Solomon

  12. Computational Search for Potential COVID-19 Drugs from Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Targets

    Article • Current Computer - Aided Drug Design, February 2023, Bentham Science Publishers

    Dr Shyam Sundar Pottabathula, Viswas Raja Solomon

  13. Identification of plant secondary metabolites as dengue envelope protein entry inhibitors through an in-silico approach

    Article • Journal of medical pharmaceutical and allied sciences, August 2022, Medic Scientific

    Dr Shyam Sundar Pottabathula

  14. Discovery of Immunomodulators from Plant Kingdom Targeting IL-6 for the Effective Management Therapy of SARS-CoV-2

    Article • Journal of Natural Remedies, April 2022, Informatics Publishing Limited

    Dr Shyam Sundar Pottabathula

  15. Dengue Virus Entry/Fusion Inhibition By Small Bioactive Molecules: A Critical Review

    Article • Mini-Reviews in Medicinal Chemistry, March 2022, Bentham Science Publishers

    Dr Shyam Sundar Pottabathula, Jubie Jawahar

  16. Distinct Modulation of Wild-Type and Selective Gene Mutated Vitamin D Receptor by Essential Polyunsaturated Fatty Acids

    Article • Mini-Reviews in Medicinal Chemistry, November 2021, Bentham Science Publishers

    Dr Shyam Sundar Pottabathula, Jubie Jawahar, BALAJI HARI

  17. POTENTIAL COUMARIN THIOSEMICARBAZONE HYBRIDS AS BRCA-1 MIMETICS FOR ER POSITIVE BREAST CANCER THERAPY: AN IN-SILICO APPROACH

    Article • Journal of medical pharmaceutical and allied sciences, October 2021, Medic Scientific

    Dr Shyam Sundar Pottabathula

  18. <i>In silico</i> Screening of Chemical Constituents in <i>Rasam</i> as a Beneficial Supplementary Treatment for Novel Coronavirus

    Article • Journal of Natural Remedies, October 2021, Informatics Publishing Limited

    Dr Shyam Sundar Pottabathula

  19. A New Class of Coumate Benzimidazole Hybrids as BRCA 1 Mimetics Through Unconventional Binding Mode; Synthesis and Preliminary Cytotoxicity Screening

    Article • Current Computer - Aided Drug Design, January 2021, Bentham Science Publishers

    Dr Shyam Sundar Pottabathula

  20. Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach

    Article • RSC Advances, January 2021, Royal Society of Chemistry

    Dr Shyam Sundar Pottabathula

  21. Targeting a conserved pocket (n-octyl-β-D–glucoside) on the dengue virus envelope protein by small bioactive molecule inhibitors

    Article • Journal of Biomolecular Structure and Dynamics, December 2020, Taylor & Francis

    Dr Shyam Sundar Pottabathula

  22. Dual Modulators of p53 and Cyclin D in ER Alpha Signaling by Albumin Nanovectors Bearing Zinc Chaperones for ER Positive Breast Cancer Therapy

    Article • Mini-Reviews in Medicinal Chemistry, November 2020, Bentham Science Publishers

    Jubie Jawahar, Ashish Wadhwani, Dr Shyam Sundar Pottabathula

  23. Synthesis of novel 2-phenyl-3-[2-(substituted amino) ethylamino] quinazolin-4(3H)-ones as a new class of H1-antihistaminic agents

    Article • Medicinal Chemistry Research, September 2012, Springer Science + Business Media

    Dr Shyam Sundar Pottabathula, Viswas Raja Solomon